Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
91
-
Total 13F shares, excl. options
-
25.1M
-
Shares change
-
+779K
-
Total reported value, excl. options
-
$263M
-
Value change
-
+$7.5M
-
Number of buys
-
34
-
Number of sells
-
-54
-
Price
-
$10.50
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q1 2016
108 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q1 2016.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 91 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 25.1M shares
of 37.4M outstanding shares and own 66.95% of the company stock.
Largest 10 shareholders include WYNNEFIELD CAPITAL INC (2.68M shares), NWQ INVESTMENT MANAGEMENT COMPANY, LLC (2.48M shares), DIMENSIONAL FUND ADVISORS LP (2.3M shares), FRANKLIN RESOURCES INC (2.14M shares), ARIEL INVESTMENTS, LLC (1.62M shares), Boston Partners (1.13M shares), VANGUARD GROUP INC (1.1M shares), ROYAL BANK OF CANADA (1.06M shares), HEARTLAND ADVISORS INC (1.05M shares), and ROYCE & ASSOCIATES LP (1.02M shares).
This table shows the top 91 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.